Clinical Trials Directory

Trials / Unknown

UnknownNCT04492969

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs

Prospective Observational Study of Failure Patterns in Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors

Status
Unknown
Phase
Study type
Observational
Enrollment
320 (estimated)
Sponsor
Fudan University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

By prospectively observing the time to the best therapeutic effect of non-small cell lung cancer after ICI treatment, the characteristics of lesion distribution when the best therapeutic effect is reached, and the phenotype of disease progression after ICI treatment response, the investigators intended to explore the failure pattern of NSCLC after the once effective ICI treatment. The investigators also aim to evaluate the feasibility and clinical value of radiotherapy for the treatment of oligo-progressive lesions after ICI.

Conditions

Timeline

Start date
2020-09-01
Primary completion
2023-08-31
Completion
2025-08-31
First posted
2020-07-30
Last updated
2020-07-31

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04492969. Inclusion in this directory is not an endorsement.

Prospective Observation of Failure Patterns in NSCLC Treated With ICIs (NCT04492969) · Clinical Trials Directory